RxDoctor Payments DataLook up a doctor →

Carl Balog, MD

Interventional Pain Medicine · Portland, ORNPI 1447287636

Payments from drug & device makers

$58,998in general payments, 2019–2025

Across 624 payments — averaging $94.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mesoblast, Inc.$47K
  • AbbVie$2K
  • Amgen$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$793
  • Collegium Pharmaceutical, Inc.$678
  • Relievant Medsystems, Inc.$620
  • plus $7K from 44 others
$2,350in research payments, 2019–2025

Across 3 payments — averaging $783.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Surgalign Spine Technologies, Inc.$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Mesoblast, Inc.5$47,379
AbbVie(2 entities)90$1,608
Amgen62$1,062
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC50$793
Collegium Pharmaceutical, Inc.50$678
Relievant Medsystems, Inc.5$620
Biotronik NRO, Inc.14$584
Pfizer32$452
Radius Health, Inc.18$445
Merz North America, Inc.5$421
Abbott11$411
Teva Pharmaceuticals USA, Inc.51$352
Boston Scientific6$314
Medtronic(3 entities)11$310
Arbor Pharmaceuticals, Inc.21$298
Daiichi Sankyo Inc.32$298
Upsher-smith Laboratories LLC19$295
Supernus Pharmaceuticals, Inc.23$275
Lilly USA, LLC12$220
Kowa Pharmaceuticals America, Inc.13$211
Biohaven Pharmaceutical Holding Company Ltd.5$196
MDD US Operations, LLC10$143
Biodelivery Sciences International, Inc.11$143
Tersera Therapeutics LLC4$128
Novartis8$128
Idorsia Pharmaceuticals US Inc5$111
Surgalign Spine Technologies, Inc.1$109
Takeda Pharmaceuticals U.S.A., Inc.8$102
Biohaven Pharmaceuticals, Inc.5$91
Nalu Medical, Inc.3$90
Scilex Pharmaceuticals Inc.5$77
Bioventus LLC3$75
Redhill Biopharma Inc.3$64
Eisai Inc.3$61
Azurity Pharmaceuticals, Inc.2$46
Zyla Life Sciences, Inc.3$45
Kaleo, Inc.2$40
Vertos Medical, Inc.1$40
Spinefrontier, Inc.1$38
Saluda Medical Americas, Inc.1$29
Merz Pharmaceuticals, LLC1$28
MML US, Inc.1$28
VBI Vaccine (delaware) Inc.1$27
Nevro Corp.1$25
GRT US Holding, Inc.1$25
Vertex1$23
Stryker1$20
Vertiflex, Inc.1$16
Pacira Pharmaceuticals Incorporated1$11
Alfasigma USA, Inc.1$11

How this compares

$58,998 in reported general payments places this provider in the 85th percentile of 22 interventional pain medicine providers in Oregon.

See all interventional pain medicine providers in Oregon →

Medicare billing

Part B allowed, 2024
$67,419
Medicare patients
89
Services billed
586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Portland

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →